Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
   

 

TTD Drug ID: DNCL001859

Drug Information
NameCangrelor
CompanyThe Medicines Company Parsippany, NJ
IndicationPrevention of coronary thrombosis (see also ischemic disorders)
[ICD9: 414.8, 437.6, 453, 671.5, 671.9   ICD10: I24.0, I80-I82]
Phase II    
Prevention of ischemic heart disorders (see also thrombosis)
[ICD9: 437.6, 453, 671.5, 671.9   ICD10: I80-I82]
Phase III    
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
InChI1S/C17H25Cl2F3N5O12P3S2/c1-43-5-3-23-12-9-13(26-15(25-12)44-4-2-1
6(20,21)22)27(7-24-9)14-11(29)10(28)8(38-14)6-37-42(35,36)39-41(3
3,34)17(18,19)40(30,31)32/h7-8,10-11,14,28-29H,2-6H2,1H3,(H,33,34
)(H,35,36)(H,23,25,26)(H2,30,31,32)/t8-,10-,11-,14-/m1/s1
InChIKeyPAEBIVWUMLRPSK-IDTAVKCVSA-N
Canonical SMILESCSCCNC1=NC(=NC2=C1N=CN2C3C(C(C(O3)COP(=O)(O)OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)
O)O)SCCC(F)(F)F    
Isomeric SMILESCSCCNC1=NC(=NC2=C1N=CN2[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)OP(=O)(C(P
(=O)(O)O)(Cl)Cl)O)O)O)SCCC(F)(F)F
FormulaC17H25Cl2F3N5O12P3S2
PubChem Compound IDCID 9854012.



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

   
 
 
Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links

 

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543